Lack of complications in skin surgery of patients receiving clopidogrel as compared with patients taking aspirin, warfarin, and controls

American Surgeon

Volumn 76, Issue 1, 2010, Pages 11-14

  Kramer, Eyal ^a,b   Hadad, Eran ^a,b   Westreich, Melvyn ^a,b   Shalom, Avshalom ^a,b  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; WARFARIN; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE; TICLOPIDINE;

AGE; AGED; ANAMNESIS; ARTICLE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; ERYTHEMA; EXCISION; FEMALE; FOLLOW UP; HEART DISEASE; HEMATOMA; HUMAN; HYPERTENSION; LOCAL ANESTHESIA; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; SEX DIFFERENCE; SKIN DEFECT; SKIN SURGERY; SURGICAL INFECTION; WOUND DEHISCENCE; WOUND ERYTHEMA; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG COMBINATION; DRUG TOXICITY; SKIN;

AGED; ANTICOAGULANTS; ASPIRIN; CASE-CONTROL STUDIES; DRUG THERAPY, COMBINATION; DRUG TOXICITY; ERYTHEMA; FEMALE; FOLLOW-UP STUDIES; HEMATOMA; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; SKIN; SURGICAL WOUND DEHISCENCE; SURGICAL WOUND INFECTION; TICLOPIDINE; WARFARIN;

EID: 77949317219     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ito MK, Smith AR, Lee ML. Ticlopidine: a new platelet aggregation inhibitor. Clin Pharm 1992;11:603-17.
2. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996;348:1329-39.
3. Khalifeh MR, Redett RJ. The management of patients on anticoagulants prior to cutaneous surgery: case report of a thromboembolic complication, review of the literature, and evidence-based recommendations. Plast Reconstr Surg 2006;118:110e-7e.
4. Kovich O, Otley CC. Perioperative management of anticoagulants and platelet inhibitors for cutaneous surgery: a survey of current practice. Dermatol Surg 2002;28:513-7.
5. Bornstein NM. Antiplatelet drugs: how to select them and possibilities of combined treatment. Cerebrovasc Dis 2001; 11(Suppl 1):96-9.
6. Hankey GJ. Current oral antiplatelet agents to prevent atherothrombosis. Cerebrovasc Dis 2001;11(suppl 2):11-7.
7. Weksler BB. Antiplatelet agents in stroke prevention. Combination therapy: present and future. Cerebrovasc Dis 2000; 10(suppl 5):41-8.
8. Savitz SI, Gupta G, Singh M, Rosenbaum DM. Antithrombotic and thrombolytic therapy for ischemic stroke. Clin Geriatr Med 2001;17:149-61.
9. Van De Graaff E, Steinhubl SR. Complications of oral antiplatelet medications. Curr Cardiol Rep 2001;3:371-9.
10. del Zoppo GJ. Antithrombotic treatments in acute ischemic stroke. Curr Opin Hematol 2000;7:309-15.
11. Diener HC. Stroke prevention: antiplatelet and antithrombotic therapy. Haemostasis 2000;30(suppl 3):14-26.
12. del Zoppo GJ. The role of platelets in ischemic stroke. Neurol (Tokyo) 1998;3(suppl):S9-14.
13. Peverill RE.Warfarin or aspirin: both or others? Med J Aust 1999;171:321-6.
14. Hart RG, Halperin JL. Atrial fibrillation and stroke: concepts and controversies. Stroke 2001;32:803-8.
15. Segal JB, McNamara RL, Miller MR, et al. Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter. In: The Cochrane Library, Vol 4. Oxford: Update Software, 2001.
16. Wong CK, White HD. Medical treatment for acute coronary syndromes. Curr Opin Cardiol 2000;15:441-62.
17. Lewis HD Jr, Davis JW, Archibald DG, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina: result of a Veterans Administration Cooperative Study. N Engl J Med 1983;309:396-403.
18. Cairns JA, Gent M, Singer J. Aspirin, sulfinpyrazone, or both in unstable angina. N Engl J Med 1985;313:1369-75.
19. Theroux P, Ouimet H, McCans J. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med 1988;319:1105-11.
20. RISC Group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 1990;336:827-30.
21. Otley CC, Fewkes JL, Frank SM, Olbricht SM. Complications of cutaneous surgery in patients who are taking warfarin, aspirin, or nonsteroidal anti-inflammatory drugs. Arch Dermatol 1996;132:161-6.
22. Billingsley EM, Maloney ME. Intraoperative and post-operative bleeding problems in patients taking warfarin, aspirin, and nonsteroidal anti-inflammatory agents. A prospective study. Dermatol Surg 1997;23:381-5.
23. Schanbacher CF, Bennett RG. Postoperative stroke after stopping warfarin for cutaneous surgery. Dermatol Surg 2000;26: 785-9.
24. Alam M, Goldberg LH. Serious adverse vascular events associated with perioperative interruption of antiplatelet and anticoagulant therapy. Dermatol Surg 2002;28:992-8.
25. Shalom A, Klein D, Friedman T, Westreich M. Lack of complications in minor skin lesion excisions in patients taking aspirin or warfarin. Am Surg 2008;74:354-7.